Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Hallberg O, Johansson O. Malignant melanoma of the skin: not a sunshine story! Med Sci Monit 2004; 10: 336–340.
2. Belhocine TZ, Scott AM, Even-Sapir E, et al. Role of nuclear medicine in the management of cutaneous malignant melanoma. J Nucl Med 2006; 47: 957–967.
3. Balch CM, Soong SJ, Atkins MB, et al. An evidencebased staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54: 131–149.
4. Jost LM, ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of cutaneous malignant melanoma. Ann Oncol 2003; 14: 1012–1013.
5. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996; 14: 7–17.